APRA finalises capital reforms for longevity products
The Australian Prudential Regulation Authority has finalised landmark amendments to its capital treatment of longevity products.
Every story in this section, newest first — page 200 of 294.
The Australian Prudential Regulation Authority has finalised landmark amendments to its capital treatment of longevity products.
Hastings Technology Metals (ASX:HAS) announced the acquisition of a fully permitted hydrometallurgical processing facility in Kabin Buri, Thailand.
The Reserve Bank of Australia announced a landmark ban on card surcharging effective Oct. 1.
Paradigm Biopharmaceuticals (ASX:PAR) confirmed that 50% of the required participants have now been dosed in its PARA_OA_012 Phase 3 clinical trial.
Miramar Resources (ASX:M2R) has expanded the mineralised footprint at its flagship project a 10,000-meter diamond drill program.
Nexsen (ASX:NXN) was awarded a HK$6 million IGNITE Grant to its subsidiary, Nexsen Hong Kong.
Anthony Albanese denies a US-Australia rift while seeking clarity from President Trump on Iran war objectives and calling for global economic de-escalation.
KMD Brands (ASX:KMD) reported total H1 FY26 sales of NZ$505.4 million, representing a 7.3% increase compared to the same period last year.
West African Resources (ASX:WAF) is forecasting record gold production for 2026 as it transitions into a multi-asset producer.
Collins Foods (ASX:CKF) has entered into a legally binding conditional arrangement to transition the majority of its Taco Bell operations.
Advanced Innergy (ASX:AIH) formalised a non-binding indicative proposal to acquire 100% of the shares in Matrix Composites & Engineering (ASX:MCE).
Australia is set to intensify its trade diplomacy as Trade Minister Don Farrell confirms a new round of high-level negotiations with India scheduled for the coming weeks.
AUD and NZD hit multi-month lows as Middle East conflict fears drive a flight to the US dollar.
Alterity Therapeutics (ASX:ATH) announced alignment with the US Food and Drug Administration following a pivotal Type C meeting.
Mining giant Rio Tinto (ASX:RIO) has reaffirmed its full-year shipment guidance for its Pilbara iron ore operations.
Aroa Biosurgery (ASX:ARX) has achieved a clinical milestone following the completion of its randomised controlled trial for Symphony.
Godolphin Resources (ASX:GRL) said exploration activities have escalated at the Lewis Ponds Gold, Silver, and Base Metals Project.
BrainChip (ASX:BRN) has secured a global, non-exclusive licensing agreement with EDGEAI for its Akida 2 neuromorphic intellectual property.
Cannindah Resources (ASX:CAE) has commenced a diamond drilling program at its Southern Porphyry copper-gold target.
QX Resources (ASX:QXR) achieved a milestone with the granting of the final two exploration licences for its Madaba Uranium Project.
Red Mountain Mining (ASX:RMX) announced a breakthrough at its 100% owned Armidale Antimony-Gold Project in New South Wales.
Xenitra (ASX:XEN) announced an escalation of its presence in the Chinese market through a dual-agreement strategic partnership with the multi-billion dollar Rockcheck Group.
Greatland Resources (ASX:GGP) announced a150% increase to its Telfer gold resource, which now stands at 8 million ounces.
Tartana Minerals (ASX:TAT) is fast-tracking its flagship Tartana Copper Project in North Queensland.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy